About: Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.49 (-0.15%)
ACHV NASDAQ Achieve Life Sciences Inc
Achieve Life Sciences Inc share price
Atividade de preço de ACHV
Último preço
$ 6,490
Variação (24h)
-0,01 USD (0,15%)
Volume
587.86K
Volume (média 4 sem.)
-
Abertura
$ 6,48
Variação do dia
$ 6,36 - $ 6,61
Fechamento anterior
$ 6,50
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
ACHV price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals